“These proposals should be regarded as a staged agenda for evaluation; their relevance will depend on whether they deliver measurable gains in patient-relevant outcomes, feasibility, and cost-effectiveness within the SSN.”
BUFFALO, NY — July 30, 2026 — A new research perspective was published in Volume 18 of Aging on July 16, 2026, titled “Towards integration of healthspan strategies into the Italian National Health Service.”
The article was led by co-first authors Nicola Marino, affiliated with the AEON Foundation and the Women’s Brain Foundation, and Matteo Fiore from the University of Bologna, with both serving as corresponding authors. Rather than presenting new clinical trial results, the authors propose a prevention-focused framework for the staged, evidence-based evaluation and integration of healthspan strategies into Italy’s National Health Service (Servizio Sanitario Nazionale, SSN) to help address the challenges of an aging population.
Italy has one of the oldest populations in the world. Although life expectancy has continued to increase, many older adults spend a substantial portion of those additional years living with chronic disease, disability, or reduced physical and cognitive function. The authors describe this mismatch as the lifespan–healthspan divide and argue that healthcare systems should increasingly focus not only on helping people live longer, but also on extending the years they remain healthy and functionally independent.
To address this challenge, the authors outline the concept of longevity medicine, describing it as a prevention-oriented, life-course framework rather than a new medical specialty. The approach integrates principles from geroscience, preventive medicine, and personalized healthcare with the goal of identifying age-related risks earlier and promoting healthy aging before chronic diseases and functional limitations accumulate. At the same time, the paper emphasizes that many emerging tools—including biological-age biomarkers, multi-omic profiling, wearable sensor data, and artificial intelligence-based risk stratification—remain exploratory and should not be adopted routinely until they demonstrate clear clinical utility, cost-effectiveness, and meaningful benefits for patients.
The perspective also examines several factors contributing to Italy’s healthspan gap, including regional healthcare disparities, physical inactivity, environmental exposures, social isolation, medication burden, and differences in aging between women and men. According to the authors, these challenges are compounded by structural limitations within the SSN, including fragmented regional healthcare delivery, hospital-centered care, limited interoperability of digital health records, and a historically modest share of healthcare spending devoted to prevention. Together, these factors highlight the need to shift from a predominantly reactive healthcare model toward one that prioritizes prediction, prevention, personalization, and patient participation throughout life.
To support this transition, the authors propose five strategic investment priorities for the Italian National Health Service. These include developing clinically validated biomarkers of biological age, expanding interoperable digital monitoring platforms, using Bayesian adaptive clinical trial designs to evaluate multiple interventions more efficiently, developing explainable artificial intelligence tools for risk stratification, and strengthening healthy-aging education for healthcare professionals and improving health literacy among the public. Importantly, the paper emphasizes that these recommendations represent a roadmap for future evaluation rather than validated clinical solutions ready for widespread implementation.
“The challenge is not only scientific, but organizational: moving from promising pilots to scalable, evidence-based programs that preserve functional capacity and resilience, and that can be rigorously evaluated and equitably implemented within the SSN.”
The authors also emphasize the importance of multidisciplinary translational research in advancing healthspan science. They argue that progress will require collaboration among clinicians, geroscientists, epidemiologists, behavioral scientists, health economists, and policymakers to determine which interventions meaningfully improve physical function, resilience, multimorbidity, and other patient-centered outcomes. Existing research initiatives, including the NIH Translational Geroscience Network, European biobank infrastructures, and Italy’s Age-It program, could provide valuable foundations for coordinated translational aging research and more comparable early-phase geroscience studies.
Overall, this research perspective presents a strategic vision for integrating healthspan-oriented approaches into the Italian National Health Service. Rather than advocating immediate adoption of emerging longevity technologies, the authors call for rigorous validation, careful implementation, and continued investment in prevention-focused research. If supported by stronger clinical evidence and effective health-system integration, they suggest that Italy could serve as a natural testbed for evaluating healthspan-oriented models of care designed to improve healthy aging while reducing the long-term burden of chronic disease and disability.
Paper DOI: https://doi.org/10.18632/aging.206402
Corresponding authors: Nicola Marino – [email protected], Matteo Fiore – [email protected]
Keywords: preventive, longevity, national health system, health span, biomarkers
Click here to sign up for free Altmetric alerts about this article.
______
To learn more about the journal, please visit www.Aging-US.com and connect with us on social media:
- Bluesky
- ResearchGate
- X
- YouTube
- Spotify, and available wherever you listen to podcasts
Click here to subscribe to Aging publication updates.
For media inquiries, please contact [email protected].